News Conference News TCT 2020 Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results Michael O'Riordan October 16, 2020
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
News Daily News Pesco-Mediterranean Diet Should Be the Gold Standard, Says JACC Review Caitlin E. Cox September 15, 2020
News Conference News SCCT 2020 For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change Yael L. Maxwell July 28, 2020
News Conference News ISC 2020 Industry Payments to Vascular Neurologists Jump in the Thrombectomy Era Todd Neale February 29, 2020
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News HRS 2019 HRS Urges Members to Get Aboard the Digital Health Train Todd Neale May 10, 2019
News Daily News Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study L.A. McKeown March 29, 2019
News Conference News ACC 2019 Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery Michael O'Riordan March 17, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Daily News Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns Michael O'Riordan November 28, 2018
News Conference News AHA 2018 New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening Michael O'Riordan November 10, 2018
News Conference News TCT 2018 PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience L.A. McKeown September 27, 2018
News Daily News Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk Michael O'Riordan June 20, 2018
News Conference News CRT 2018 Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018 Michael O'Riordan March 06, 2018
News Conference News CRT 2018 Early Low-Risk TAVR Data Reassure, but Durability Questions Remain Michael O'Riordan March 05, 2018